Curt H. LaBelle's most recent trade in Revelation Biosciences Inc was a trade of 6,356 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 14, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Revelation Biosciences Inc | Curt H. LaBelle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 6,356 | 6,356 | - | - | Stock Option (Right to Buy) | |
Eyenovia Inc | Curt H. LaBelle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2021 | 9,653 | 9,653 | - | - | Stock Option (right to buy) | |
Eyenovia Inc | Curt H. LaBelle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2021 | 6,963 | 42,236 (0%) | 0% | 0 | Common Stock, par value $.0001 |